FDA Breakthrough designation supports development of a point-of-care test for detecting folate receptor autoantibodies ...
The U.S. Food and Drug Administration is considering approval of the drug leucovorin to treat children with cerebral folate deficiency and symptoms of autism. Kevin Pelphrey is the Harrison-Wood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback